peptide conjugated phosphorodiamidate morpholino oligomer designed to specifically bind to mRNA - PPMO drug have the potential of being used as antisense antibiotics Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers: A Novel Therapeutic Frontier

PPMO meaning Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) represent a significant advancement in nucleic acid-based therapeutics, offering a unique approach to target gene expression and combat challenging diseases.Peptide-Conjugated Phosphorodiamidate Morpholino ... These synthetic molecules, which have a structure similar to DNA or RNA, combine the sequence-specific targeting capabilities of morpholino oligomers with the enhanced delivery and targeting potential of peptides. This synergistic combination has opened new avenues for treating conditions ranging from infectious diseases to genetic disorders.

At its core, the peptide-conjugated phosphorodiamidate morpholino oligomer system leverages the power of antisense technology. Phosphorodiamidate morpholino oligomers (PMOs) themselves are synthetic nucleotide analogues designed to bind specifically to messenger RNA (mRNA) sequences作者：DS Youngblood·2007·被引用次数：256—Inhibition of Interferon Alpha by aPeptide-Conjugated Phosphorodiamidate Morpholino OligomerIncreases Influenza Virus Replication in Chicken Embryo .... This binding event effectively prevents the translation of the targeted mRNA into proteins, thereby modulating gene expression"Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)restores carbapenem susceptibility to NDM-1-positive pathogensin vitro and in vivo". The .... The unique backbone of morpholino oligomers, characterized by phosphorodiamidate linkages instead of phosphodiester bonds found in natural nucleic acids, confers increased resistance to nucleases, leading to improved stability and longevity within biological systemsPhosphorodiamidate morpholino oligomers (PMOs) restore the DMD reading frame, allowing for production of an internally truncated but functional dystrophin ....

The conjugation of peptides to these phosphorodiamidate morpholino oligomers is a critical innovation.作者：DS Youngblood·2007·被引用次数：256—Inhibition of Interferon Alpha by aPeptide-Conjugated Phosphorodiamidate Morpholino OligomerIncreases Influenza Virus Replication in Chicken Embryo ... Peptides can be engineered to possess specific properties, such as cell-penetrating capabilities or affinity for particular cell types or tissues. For instance, using peptide CP10 as a conjugate to phosphorodiamidate morpholino oligomers has been explored for improved delivery to muscle tissue, a crucial aspect for treating genetic muscle disorders like Duchenne muscular dystrophy (DMD). Similarly, research into cell-penetrating peptides (CPPs) has demonstrated their ability to enhance the cellular uptake of PMOs, overcoming a common hurdle in the delivery of nucleic acid-based therapeutics. This conjugation process allows for more precise delivery of the therapeutic payload, minimizing off-target effects and maximizing efficacy2025年8月9日—Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)restores carbapenem susceptibility to NDM-1-positive pathogensin vitro and in ....

The therapeutic applications of PPMOs are diverse and expanding. In the realm of infectious diseases, peptide-conjugated phosphorodiamidate morpholino oligomer-PPMO constructs have shown remarkable promise.2014年5月22日—Peptide Conjugated Phosphorodiamidate Morpholino OligomersIncrease Survival of Mice Challenged with Ames Bacillus anthracis · Medicine, Biology. Studies have demonstrated that these molecules can restore carbapenem susceptibility to NDM-1-positive pathogens by targeting essential genes within bacteria, thereby re-sensitizing them to previously ineffective antibiotics. This development is particularly significant in the face of rising antimicrobial resistance, offering a potential strategy to combat multidrug-resistant infections.作者：DE Greenberg·2010·被引用次数：103—Peptide-conjugated PMOs (PPMOs) were developed to target acpP, which encodes an acyl carrier protein (AcpP) that is thought to be essential for growth. For example, research has shown that Peptide Conjugated Phosphorodiamidate Morpholino Oligomers have the potential of being used as antisense antibiotics to treat infections caused by pathogens like *Bacillus anthracis*.

Beyond infectious diseases, PPMOs are also being investigated for their potential in treating genetic disordersStability of Cell-Penetrating Peptide−Morpholino Oligomer .... In Duchenne muscular dystrophy (DMD), a debilitating genetic condition characterized by the absence of functional dystrophin protein, PPMOs can be designed to correct the underlying genetic defect. Specifically, these molecules can facilitate exon skipping, a process that restores the reading frame of the dystrophin gene, allowing for the production of a truncated but functional dystrophin protein作者：DA Moustafa·2021·被引用次数：41—Peptide-Conjugated Phosphorodiamidate Morpholino OligomersRetain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In .... This approach has led to promising results in preclinical models, where PPMOs have been shown to restore the DMD reading frame, enabling the production of internally truncated but functional dystrophin. Furthermore, investigations into novel antisense oligonucleotide conjugates that cause exon skipping in the human dystrophin gene highlight the therapeutic potential in treating Duchenne muscular dystrophyAntisense Morpholino Oligomers and Their Peptide Conjugates.

The scientific community's interest in peptide-conjugated phosphorodiamidate morpholino oligomers is reflected in the extensive research, including the Synthesis of peptide-conjugated phosphorodiamidate morpholino oligonucleotides. The development and refinement of synthetic methodologies are crucial for producing these complex molecules with high purity and yield, ensuring their suitability for therapeutic usePeptide Conjugated Phosphorodiamidate Morpholino .... The ongoing research into molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides further contributes to a deeper understanding of their behavior and optimization for clinical applications.

The PPMO oligonucleotide platform, therefore, represents a sophisticated therapeutic modality. The PPMO meaning extends beyond a simple chemical structure; it embodies a strategy to precisely modulate gene expression for therapeutic benefit2025年8月9日—Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)restores carbapenem susceptibility to NDM-1-positive pathogensin vitro and in .... The PPMO drug development pipeline is actively exploring various disease targets, leveraging the unique advantages of conjugated morpholino oligomersAntisense Phosphorodiamidate Morpholino Oligomers .... While PPMO project management is a complex undertaking, the potential rewards in addressing unmet medical needs are substantial. The exploration of different peptides for conjugation, such as the aforementioned peptide CP10, allows for tailored delivery strategies, enhancing the overall therapeutic efficacy. Ultimately, peptide-conjugated phosphorodiamidate morpholino oligomers stand as a testament to the power of interdisciplinary innovation in molecular medicine, offering hope for new and effective treatments for a range of debilitating conditions.